• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Compound CAS No. 347840-19-1: (±)-Mevalonolactone-4,4,5,5,6,6,6-d7

The compound CAS No. 347840-19-1, also known as (±)-Mevalonolactone-4,4,5,5,6,6,6-d7, is a highly specialized isotopically labeled derivative of mevalonolactone. This compound has gained significant attention in recent years due to its unique properties and applications in various fields of research. Mevalonolactone itself is a naturally occurring compound that plays a crucial role in the mevalonate pathway, which is essential for the biosynthesis of cholesterol and other isoprenoid compounds. The addition of deuterium atoms at specific positions (positions 4, 5, and 6) in the structure of mevalonolactone creates a stable isotopic tracer that is widely used in metabolic studies and drug development.

Mevalonolactone is a cyclic ester derived from mevalonic acid, which is an intermediate in the biosynthesis of cholesterol. The mevalonate pathway is a critical metabolic pathway in eukaryotic organisms and has been extensively studied for its role in lipid metabolism and cell signaling. The isotopic labeling of mevalonolactone with deuterium atoms at positions 4, 5, and 6 (d7) provides researchers with a powerful tool to track the fate of this compound within biological systems. This labeling allows for precise measurement of metabolic fluxes and enzyme activities using techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy.

The synthesis of (±)-Mevalonolactone-4,4,5,5,6,6,6-d7 involves a multi-step process that requires careful control over stereochemistry and isotopic purity. Recent advancements in synthetic chemistry have enabled the production of this compound with high yield and excellent isotopic enrichment. The stereochemical configuration (±) indicates that the compound exists as a racemic mixture of enantiomers. This property makes it suitable for use in both enantioselective studies and applications where stereochemical uniformity is not required.

One of the most significant applications of (±)-Mevalonolactone-4,4,5,5,6,6,d7 is in metabolic research. By incorporating this compound into cellular or animal models, researchers can study the dynamics of lipid metabolism under various physiological or pathological conditions. For example, recent studies have utilized this compound to investigate the effects of statins on cholesterol biosynthesis and to explore novel therapeutic targets for dyslipidemia and related cardiovascular diseases.

In addition to its role as an isotopic tracer in basic research, (±)-Mevalonolactone-4,d7 has also found applications in drug development. The ability to track the fate of this compound within biological systems makes it an invaluable tool for pharmacokinetic studies. Researchers can use this compound to assess drug absorption、distribution、metabolism、and excretion (ADME) properties with high precision.

Recent advances in mass spectrometry techniques have further enhanced the utility of (±)-Mevalonolactone-4,d7 as an analytical tool. High-resolution mass spectrometry (HRMS) allows for precise identification and quantification of this compound even at trace levels within complex biological matrices. This capability has been instrumental in advancing our understanding of lipid metabolism and its regulation under various conditions.

In conclusion, CAS No. 347840-19-1, or (±)-Mevalonolactone-4,d7, represents a valuable tool for researchers studying lipid metabolism、drug development、and metabolic regulation. Its unique properties as an isotopic tracer make it indispensable for advancing our understanding of fundamental biological processes while providing practical applications in clinical research and therapeutic development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)